Krystal Biotech, Inc. (KRYS)
257.14
+2.19
(+0.86%)
USD |
NASDAQ |
Mar 26, 10:43
Krystal Biotech Cash from Investing (Quarterly) : 11.16M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -6.494M |
| Scholar Rock Holding Corp. | 38.97M |
| Alkermes Plc | 322.35M |
| Stoke Therapeutics, Inc. | -61.06M |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 77.51M |
| Cash from Financing (Quarterly) | 15.67M |
| Free Cash Flow | 188.91M |
| Free Cash Flow Per Share (Quarterly) | 2.492 |
| Free Cash Flow to Equity (Quarterly) | 75.54M |
| Free Cash Flow to Firm (Quarterly) | 75.37M |
| Free Cash Flow Yield | 2.46% |